D-0151-2020 Class II Terminated
FDA drug recall D-0151-2020 was initiated by Nephron Pharmaceuticals Corporation Dba Nephron Sterile Compounding Center on Oct 9, 2019 and is designated Class II. Reason for recall: Lack of Assurance of Sterility; bags have potential to leak The recall status is terminated (terminated Dec 1, 2020). Affected quantity: 1047 bags.
Recall details
- Product Type
- Drugs
- Report Date
- Oct 30, 2019
- Initiation Date
- Oct 9, 2019
- Termination Date
- Dec 1, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1047 bags
Product description
del Nido Cardioplegia Solution, 1000 mL, Single-Dose Container, Rx Only Nephron 503B Outsourcing Facility 4500 12th St. Extension West Columbia, SC 29172 NDC: 69374-984-10
Reason for recall
Lack of Assurance of Sterility; bags have potential to leak
Distribution pattern
Nationwide.
Code information
Lots: NC9048A Exp. 10/14/2019; NC9048B Exp. 10/14/2019; NC9049A Exp. 10/16/2019; NC9049B Exp. 10/16/2019; NC9051A Exp. 10/21/2019; NC9051B Exp. 10/21/2019; NC9052A Exp. 10/22/2019; NC9052B Exp. 10/22/2019; NC9053A Exp. 10/23/2019; NC9053B Exp. 10/23/2019; NC9054A Exp. 10/28/2019; NC9054B Exp. 10/28/2019; NC9055A Exp. 10/30/2019; NC9056B Exp. 11/04/2019
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0151-2020
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026